从挽救到预防:脱细胞真皮基质与感染在胸肌前乳房再造中的单术者经验
该单术者回顾性研究纳入2017年2月至2020年7月接受即刻胸肌前乳房再造的患者,因感染率上升,2019年1月将引流方案改变并将脱细胞真皮基质从AlloDerm(无菌保证水平10-3)换为DermACELL(无菌保证水平10-6)。结果显示DermACELL组感染率显著低于AlloDerm组[2/38(5.3%)比11/41(26.8%),p=0.014],尽管DermACELL组直接置入假体和双侧手术比例更高、假体体积更大。
要点
- 胸肌前乳房再造中,DermACELL较AlloDerm感染率显著降低(5.3% vs 26.8%,p=0.014)。
- 脱细胞真皮基质的类型、处理工艺和无菌保证水平可能影响术后感染风险。
- 需进一步研究明确脱细胞真皮基质类型与处理技术对感染的作用。
核心结论
- 在胸肌前乳房再造中,使用DermACELL(无菌保证水平10-6)相比AlloDerm(无菌保证水平10-3)可显著降低感染率。
- 脱细胞真皮基质的整合性、无菌性和假体支撑等特性在大量使用时尤为重要。
研究设计与样本
- 单术者回顾性综述,纳入2017年2月至2020年7月接受即刻胸肌前乳房再造的患者。
- 2019年1月因感染率上升而改变引流方案并将脱细胞真皮基质从AlloDerm换为DermACELL。
- 收集人口学和手术变量以及感染发生与处理的详细信息。
主要发现
- DermACELL组感染率为5.3%(2/38),AlloDerm组为26.8%(11/41),差异有统计学意义(p=0.014)。
- DermACELL组直接置入假体和双侧手术比例更高、假体体积更大,但感染率仍更低。
- DermACELL组引流时间略长,与引流方案改变一致。
- 两组基线人口学和临床特征相似。
关键数值与推荐
- 感染率:DermACELL组2/38(5.3%),AlloDerm组11/41(26.8%),p=0.014。
- 无菌保证水平:AlloDerm为10-3,DermACELL为10-6。
临床怎么用
- 在胸肌前乳房再造中,可考虑选择无菌保证水平更高的脱细胞真皮基质以降低感染风险。
- 需结合引流方案等围手术期管理综合评估感染风险。
局限性
- 单术者回顾性研究,样本量有限。
- 同时改变了引流方案,可能存在混杂因素。
- 比较不同脱细胞真皮基质在胸肌前乳房再造中的研究较少,需进一步研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Increasing amounts of acellular dermal matrix are being used with the adoption of prepectoral breast reconstruction. Postoperative infection remains a challenge in breast reconstruction, and the contribution of acellular dermal matrix type, processing, and sterility assurance level to risk of complications in prepectoral reconstruction is not well studied. METHODS: The authors performed a retrospective review of patients who underwent immediate prepectoral breast reconstruction from February of 2017 to July of 2020. Because of an increase in the rate of infection, the drain protocol was changed and acellular dermal matrix type was switched from AlloDerm (sterility assurance level, 10-3) to DermACELL (sterility assurance level, 10-6) in January of 2019. Demographic and surgical variables were collected, in addition to details regarding development and management of infection. RESULTS: Despite higher rates of direct-to-implant reconstruction and bilateral procedures and increased implant volumes, the rate of infection was significantly lower in patients who received DermACELL instead of AlloDerm [two of 38 (5.3 percent) versus 11 of 41 (26.8 percent); p = 0.014]. Drain duration was slightly longer in the DermACELL group, consistent with the change in drain protocol. Baseline demographic and clinical characteristics remained similar between the two groups. CONCLUSIONS: With increased reliance on large amounts of acellular dermal matrix for prepectoral breast reconstruction, it directly follows that the properties of acellular dermal matrix with respect to incorporation, sterility, and implant support are that much more important to consider. There have been few studies comparing different types of acellular dermal matrix in prepectoral breast reconstruction, and further research is required to determine the contribution of acellular dermal matrix type and processing techniques to development of postoperative infection. CLINICAL QUESTION/LEVEL OF EVIDENCE: Therapeutic, III.
引用
- Powers JM, Reuter Muñoz KD, Parkerson J, et al. From Salvage to Prevention: A Single-Surgeon Experience with Acellular Dermal Matrix and Infection in Prepectoral Breast Reconstruction. Plast Reconstr Surg. 2021. PMID: 34644266. doi:10.1097/PRS.0000000000008519
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。